#read

Innovation Award of the German BioRegions 2026

D-Leipzig | Founders take note: Submit innovative ideas now and attract nationwide attention.
17/12/2025

Do you have a patented or patent-pending idea in the field of modern biotechnology, bioeconomy or medical technology related to biotechnology that has the potential to significantly influence the future?
The Innovation Award of the German BioRegions recognises outstanding, application-oriented developments with high market and implementation potential.

Why should you take part?

  • Three prizes worth 2,000 euros each
  • One audience award worth 2,000 euros
  • Germany-wide visibility for your innovation
  • Presentation to an international audience of experts, investors and representatives of the trade press
  • Invitation of the six finalists to the German Biotechnology Days on 21 and 22 April 2026 in Leipzig

What will be honoured?

The Innovation Award honours ideas that:

  • are patented or in the process of being patented,
  • have a clear application reference,
  • have strong market potential and
  • can make a relevant contribution to the economy and society
  • .

Who can apply?

  • Scientists from universities and non-university research institutions
  • Legal persons under public law (e.g. universities, universities of applied sciences, patent exploitation agencies)
  • Founders of young companies that have not yet achieved any relevant turnover and have not sold any significant shares in the company to external investors

Seize your opportunity!

Present your innovation to a high-calibre audience and receive valuable support on the way to successful implementation.

Apply now until 24 February 2026 here!

Contact person Innovation Award 2026:

BioLAGO e.V. - the health network
Eva Botzenhart-Eggstein
Mail: eva.botzenhart@biolago.org
Tel: +49 7531 - 71409 13

InfectoGnostics Forschungscampus Jena e.V.
Dr Jens Hellwage
Mail: jens.hellwage@infectognostics.de
Tel: +49 3641 - 948 309

Further information can be found here.

The above texts, or parts thereof, were automatically translated from the original language text using a translation system (DeepL API).
Despite careful machine processing, translation errors cannot be ruled out.

Click here to access the original content